Calumet, Inc. (NASDAQ:CLMT – Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Traders acquired 3,039 call options on the stock. This represents an increase of approximately 22% compared to the typical volume of 2,495 call options.
Analysts Set New Price Targets
CLMT has been the topic of several research analyst reports. The Goldman Sachs Group boosted their price objective on Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Wall Street Zen downgraded shares of Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. HC Wainwright reissued a “buy” rating and set a $33.00 target price on shares of Calumet in a research report on Monday, November 10th. Finally, Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Four equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $20.04.
View Our Latest Report on Calumet
Hedge Funds Weigh In On Calumet
Calumet Stock Performance
NASDAQ CLMT traded up $0.07 on Thursday, reaching $20.17. The stock had a trading volume of 96,490 shares, compared to its average volume of 1,001,270. The stock has a market cap of $1.75 billion, a P/E ratio of -46.89 and a beta of 1.23. Calumet has a 12-month low of $7.68 and a 12-month high of $22.10. The business’s 50-day moving average price is $19.49 and its 200 day moving average price is $17.97.
Calumet (NASDAQ:CLMT – Get Free Report) last announced its earnings results on Friday, November 7th. The oil and gas company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.09. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.06 billion. The business’s revenue was down 2.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($1.18) earnings per share. On average, sell-side analysts predict that Calumet will post -3.02 earnings per share for the current year.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
See Also
- Five stocks we like better than Calumet
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
